Literature DB >> 30725263

Gender difference in the risk for cardiovascular events or mortality of patients with diabetic foot syndrome.

Giuseppe Seghieri1, Laura Policardo2, Elisa Gualdani2, Roberto Anichini3, Paolo Francesconi2.   

Abstract

AIMS: Diabetic foot syndrome (DFS) increases the risk for atherosclerotic cardiovascular disease (ASCVD), chronic kidney disease (CKD), or mortality. The present study aims at ascertaining whether such DFS-related excess risk differs between genders, retrospectively investigating a population with diabetes from Tuscany, Italy, followed-up for 6 years (2011-2016).
METHODS: People with diabetes living in Tuscany on January 1st 2011 identified by administrative databases, were divided by baseline history of prior DFS hospitalizations, stratified by presence/absence of peripheral vascular disease and evaluating, by Cox regression analysis, whether adjusted DFS-related excess risk of incident ASCVD, CKD or mortality differed between genders.
RESULTS: In an overall population of 165,650 subjects with diabetes (81,829M/83,821F), basal prevalence of DFS was twice higher among males, who were moreover at a significantly greater risk of all considered outcomes along the 6-year period. On the contrary, baseline DFS significantly increased the hospitalization risk for ASCVD, CKD and mortality equally or at a slightly greater extent in females, while the risk for stroke was significantly associated with DFS only among females (HR: 1.622 (1.314-1.980); p = 0.0001 vs. HR: 1.132 (0.955-1.332); p = NS). This finding was even reinforced in non-vascular DFS, which was associated with a significant raised risk for stroke, heart failure or mortality exclusively in females.
CONCLUSIONS: In this population, DFS prevalence and overall risk for ASCVD, CKD or mortality were significantly higher among males. Baseline co-presence of DFS, however, conferred a similar adjusted risk for all these outcomes between genders, and in case of non-vascular DFS the risk was significantly increased only among females.

Entities:  

Keywords:  Cardiovascular diseases; Chronic kidney disease; Diabetic foot syndrome; Gender; Mortality

Mesh:

Year:  2019        PMID: 30725263     DOI: 10.1007/s00592-019-01292-y

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  5 in total

1.  Healthcare costs of diabetic foot disease in Italy: estimates for event and state costs.

Authors:  Chiara Seghieri; Francesca Ferrè; Elisa Foresi; Alice Borghini
Journal:  Eur J Health Econ       Date:  2022-05-05

2.  Mortality Risk Associated with Diabetic Foot Complications in People with or without History of Diabetic Foot Hospitalizations.

Authors:  Piergiorgio Francia; Elisa Gualdani; Laura Policardo; Leonardo Bocchi; Flavia Franconi; Paolo Francesconi; Giuseppe Seghieri
Journal:  J Clin Med       Date:  2022-04-27       Impact factor: 4.964

3.  Survival of Patients Following First Diagnosis of Diabetic Foot Complications: A Nationwide 15-Year Longitudinal Analysis.

Authors:  Chia-Hung Lin; David G Armstrong; Pi-Hua Liu; Cheng-Wei Lin; Chung-Huei Huang; Yu-Yao Huang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-13       Impact factor: 5.555

4.  Alterations in pro- and anti-inflammatory mediators are involved in microvascular dysfunction in postmenopausal women with type 2 diabetes mellitus.

Authors:  A P Jarrete; L T Giollo-Junior; J F Vilela-Martin; I P Novais; M A Delbin; A Zanesco
Journal:  Braz J Med Biol Res       Date:  2022-02-28       Impact factor: 2.590

5.  Analysis of Diabetes Mellitus-Related Amputations in the State of Espírito Santo, Brazil.

Authors:  Wendel Jose Teixeira Costa; Nilson Penha-Silva; Italla Maria Pinheiro Bezerra; Ismar Paulo Dos Santos; José Lucas Souza Ramos; Jonathan Mendes de Castro; Júlio Eduardo Gomes Pereira; Alan Patrício da Silva; Adilson Monteiro; Luiz Carlos de Abreu
Journal:  Medicina (Kaunas)       Date:  2020-06-11       Impact factor: 2.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.